Apr Applied Pharma Research S Ais A Swiss Based Biopharmaceutical Company Focused On Nichetherapeutic Areasrarediseasesand Orphan Drug Developmentit Operates As A B2B Entityemphasizing Innovation And Formulation Expertiseto Commercializepatent Protected Products Globallyheadquartered In Balernaswitzerlandapr Addresses Unmet Medical Needs Through A Structured Process Of Identifying Therapeutic Gapsdeveloping Tailored Solutionsand Bringing Products To Market Thecompany S Portfolio Includes Treatments For Raremetabolic Disorderssuch As Thepku Golikeafamily And Olpruvaa C For Urea Cycledisordersin Dermatologyapr Offers Products Likeapr Td011 For Epidermolysis Bullosa And Apr Td012 For Hailey Hailey Diseaseadditionallyit Provides Cns Pain Management Solutionsantiemeticsadvanced Wound Carewith Nexodyna And Ocular Therapiesapr Also Offers End To End Contract Servicesincluding Formulation Development And Analytical Servicesand Engages In Licensing And B2B Partnerships To Enhanceits Reach In Specialized Markets
